Detalles de la búsqueda
1.
Peritonectomy and hyperthermic chemotherapy in patients with advanced or recurrent ephitelial ovarian cancer: a single center cohort study.
Minerva Chir
; 69(1): 17-26, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24675243
2.
Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario.
ESMO Open
; 7(2): 100406, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35219245
3.
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study.
Biomark Res
; 9(1): 57, 2021 Jul 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34256855
4.
The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer.
ESMO Open
; 6(2): 100078, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33735802
5.
Corrigendum to "Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation".
J Oncol
; 2020: 8947367, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32318109
6.
Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians' attitudes.
Clin Transl Oncol
; 22(6): 844-851, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31392645
7.
Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation.
J Oncol
; 2019: 5879616, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31827511
8.
Real world treatment practice in patients with advanced melanoma in the nivolumab era: five novel Italian case reports and a literature review.
Eur Rev Med Pharmacol Sci
; 22(8): 2490-2501, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29762855
9.
Erratum to 'Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario': [ESMO Open Volume 7, Issue 2, April 2022, 100406].
ESMO Open
; 7(2): 100471, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35378403
10.
Increased tolerability of bimonthly 12-hour timed flat infusion 5-fluorouracil/irinotecan regimen in advanced colorectal cancer: A dose-finding study.
Oncol Rep
; 15(5): 1345-50, 2006 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-16596209
11.
Corrigendum to 'The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer': [ESMO Open Volume 6, Issue 2, April 2021, 100078].
ESMO Open
; 6(3): 100137, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34144775
12.
Chronomodulated infusion of cisplatin, 5-fluorouracil and folinic acid: lack of activity in advanced colorectal cancer.
Anticancer Res
; 20(2B): 1253-6, 2000.
Artículo
en Inglés
| MEDLINE | ID: mdl-10810430
13.
A phase II study of dose-dense epirubicin plus cyclophosphamide followed by docetaxel plus capecitabine and pegfilgrastim support as preoperative therapy for patients with stage II, IIIA breast cancer.
Ann Oncol
; 18(6): 1015-20, 2007 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17369601
Resultados
1 -
13
de 13
1
Próxima >
>>